Neil Lerner - Chief Accounting Officer at Compass Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Issuer Symbol
CMPX on Nasdaq
All Insider Reports
All Insider Reports

Neil Lerner - trading volume in the past year for Compass Therapeutics, Inc.

Holdings reported by Neil Lerner for Compass Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 382,500 $1,977,525 $5.17 02 Jan 2026 Direct
Stock Option (Right to Buy) 435,000 02 Jan 2026 Direct Common Stock

Transactions reported by Neil Lerner for Compass Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.